Cationic Gold(I)-Catalyzed Cascade Bicyclizations for Divergent

Jun 11, 2018 - Divergent synthesis of these structurally complex pyrido[2,1-a]isoindol-4(6H)-ones and spiroisoquinoline-pyrrole-3,5′-diones via a ca...
0 downloads 0 Views 574KB Size
Subscriber access provided by Kaohsiung Medical University

Letter

Cationic Gold(I)-Catalyzed Cascade Bicyclizations for Divergent Synthesis of (Spiro)polyheterocycles Zhenghua Li, Liangliang Song, Luc Van Meervelt, Guilong Tian, and Erik V. Van der Eycken ACS Catal., Just Accepted Manuscript • Publication Date (Web): 11 Jun 2018 Downloaded from http://pubs.acs.org on June 11, 2018

Just Accepted “Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted online prior to technical editing, formatting for publication and author proofing. The American Chemical Society provides “Just Accepted” as a service to the research community to expedite the dissemination of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully peer reviewed, but should not be considered the official version of record. They are citable by the Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore, the “Just Accepted” Web site may not include all articles that will be published in the journal. After a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web site and published as an ASAP article. Note that technical editing may introduce minor changes to the manuscript text and/or graphics which could affect content, and all legal disclaimers and ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or consequences arising from the use of information contained in these “Just Accepted” manuscripts.

is published by the American Chemical Society. 1155 Sixteenth Street N.W., Washington, DC 20036 Published by American Chemical Society. Copyright © American Chemical Society. However, no copyright claim is made to original U.S. Government works, or works produced by employees of any Commonwealth realm Crown government in the course of their duties.

Page 1 of 7 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

ACS Catalysis

Cationic Gold(I)-Catalyzed Cascade Bicyclizations for Divergent Synthesis of (Spiro)polyheterocycles Zhenghua Li,† Liangliang Song,† Luc Van Meervelt,‡ Guilong Tian*,† and Erik V. Van der Eycken*,†,§ †

Laboratory for Organic & Microwave-Assisted Chemistry (LOMAC) and ‡Biomolecular Architecture, Department of Chemistry, KU Leuven, Celestijnenlaan 200F, Heverlee 3001, Leuven, Belgium

§

Peoples’ Friendship University of Russia (RUDN University), 6 Miklukho-Maklaya Street, Moscow, 117198, Russia

ABSTRACT: We herein report an expeditious synthetic strategy to access diverse (spiro)polyheterocycles from easily available starting materials in two operational steps including an Ugi four-component reaction and a cationic gold(I)-catalyzed cascade bicyclization. Divergent synthesis of these structurally complex pyrido[2,1-a]isoindol-4(6H)-ones and spiroisoquinoline-pyrrole-3,5'diones via a cascade nucleophilic cyclization/intramolecular 1,3-migration/1,5-enyne cycloisomerization process and a tandem hydroamination/Michael addition sequence, respectively, was controlled by substituents, where the electronic effect on the migrating groups and steric effect of the secondary amide moieties play crucial roles. KEYWORDS: gold catalysis, heterocycles, cascade cyclization, 1,3-migration, substrate control and divergent synthesis Due to the importance of heterocycles in biologically active natural products, pharmaceuticals and organic materials, organic chemists invested significant efforts in exploring effective strategies for their synthesis.1 In this regard, the intramolecular addition of various nucleophiles, such as alcohols, thiols and amines, to transition metal-activated alkynes has served as a powerful tool for constructing innumerable heterocycles in an efficient and atom-economic manner (Scheme 1a, R2 = H).2 Meanwhile, employing weaker nucleophiles, such as ethers, sulfides, tertiary amines and amides, resulted in the formation of heterocycles containing a disubstituted alkene in a single operation through rearrangement of the allyl,3 propargyl,4 acyl,5 α-alkoxy alkyl,6 sulfonyl,7 silane8 or benzyl group9 (Scheme 1a, R2 ≠ H). Furthermore, various fragment migrations have been involved as the key step in many homogeneous gold-catalyzed cascade processes for the effective synthesis of highly complex heterocycles and natural products.10 However, to the best of our knowledge, there are no reports11 where a latent nucleophilic enamine, generated via fragment migration from 2-alkynylphenyl-N,N-disubstituted ethanamine, is subsequently trapped by an extra electrophile to achieve one more heterocyclic ring. Moreover, the highly investigated Ugi four-component reaction (Ugi-4CR)12 has been widely employed to generate multifunctionalized acyclic adducts for a myriad of intramolecular cyclizations enabled by various transition-metal catalysts.13 This strategy provides an access for rapidly assemble diverse N-heterocyclic scaffolds from readily available building blocks in two operational steps, which is highly useful for high-throughput screenings in drug discovery. Among them, the cooperation of Ugi-4CR and tandem gold-catalysis has gained striking achievements for synthesizing complex heterocycles with high structural variability.13b-d Inspired by these results, we envisaged that a post-Ugi gold-catalyzed nucleophilic cyclization/1,3-migration/1,5-enyne cycloisomerization process would be quite promising to expeditiously construct

diverse pyrido[2,1-a]isoindol-4(6H)-one 2 (Scheme 1b, a→b→c route). This skeleton is often encountered in various biologically active natural products such as the antitumor alkaloid camptothecin and nothapodytines A and B (Figure. 1).14 Scheme 1. Construction of Heterocyclic Scaffolds by Transition-Metal Catalysis

On the other hand, considering the presence of the nucleophilic secondary amide introducing from Ugi-4CR, we assumed that the hydroamination of gold-activated alkyne with the nitrogen atom of the secondary amide could occur first, followed by Michael addition to the tertiary propiolamide moiety producing the spiroisoquinoline-pyrrolone 3 (Scheme 1b, d→e route), which is also interesting as similar skeletons could be found in lots of natural products as well as pharmaceutical compounds like the insecticide spiropidion (Figure 1).15 We speculated that the stabilization of the migrating

ACS Paragon Plus Environment

ACS Catalysis 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

group, as well as steric effect of the secondary amide moieties might play crucial roles in determining the possible reaction route, providing a steering handle.

Page 2 of 7

1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene, =Trifluoromethanesulfonyl.

Tf

Table 2. Scope and Limitations of the Cascade Nucleophilic Cyclization/1,3-Migration/Cycloisomerization Processa R4 HN

N

Conditions

N

2a

1a, 80% Catalyst

Solvent

T/ oC

IPrAuCl/AgOTf IPrAuCl/AgOTf IPrAuCl/AgOTf IPrAuCl/AgOTf IPrAuCl/AgOTf IPrAuCl/AgBF4 IPrAuCl/AgSbF6 IPrAuCl/AgNTf 2 Au(PPh3)Cl/AgOTf AuCl AuCl3 IPrAuCl/AgOTf IPrAuCl/AgOTf IPrAuCl AgOTf Au@Al-SBA15

DCE DCE DCE DCE DCE DCE DCE DCE DCE DCE DCE MeCN Toluene DCE DCE DCE

60 80 100 120 120 120 120 120 120 120 120 120 120 120 120 120

Yield of 2ab/% 43 54 71 81 52 72 66 75 0c 0c 0c 43 56 0c 0c 0c

N

2

7

N

R

Me

N

6'

3'

2'

Ph

2o, R3 = 2'-OMe, 0% 2p, R3 = 3'-OMe, 0% 2q, R3 = 3',4'-di-OMe, 66% 2r, R3 = 3',4',5'-tri-OMe, 60% 2s, R3 = 3',4'-OCH2O-, 51% 2t, R3 = 4'-OEt, 82% 2u, R3 = 4'-SMe, 55% CONHtBu

O N

Ph Ph 2w, 78%

2vb

,0% CONHR4 N

5'

4'

Ph

Ph

O

Ph

Ph

CONHR O

Ph

MeO

N O N

Ph R4 = Cy, 2aa, 33% R4 = Bn, 2ab, 21% R4 = nBu, 2ac, 21%

R4

3aa, 45% 3ab, 61% 3ac, 71% CONHtBu

CONHTMB N

OMe O

4

N

2y, R4 = adamantyl, 84% 2z, R4 = TMB, 80%

O

2x, 0 %

+ MeO

O

N

Ph

O

3

O

2i, R2 = 7-F, 82% 2b, R1 = H, 42% 2j, R2 = 7-Cl, 80% 2c, R1 = Me, 48% 2k, R2 = 7-Br, 68% 2d, R1 = Et, 53% 2l, R2 = 7-OMe, 56% 2e, R1 = nPr, 61% 2m, R2 = 7,8-di-OMe, 44% 2f, R1 = iPr, 60% 2n, R2 = 7,8-OCH2O-, 41% 2g, R1 = Pentyl, 71% 2h, R1 = 2-Thiophene, 78% CONHtBu CONHtBu N

R4

CONHtBu

R3

MeO

1

R

O

N

O

O N

Ph

OMe

+ R 1

9

MeO

N

+ MeO

1 2 3 4 5d 6 7 8 9 10 11 12 13 14 15 16

R2

8

O

Ph

2

CONHtBu

6

O

N

a

N R3 O

R

O

N

R CONHtBu

O Ph

1

R1

OMe CONHtBu

O

R2

DCE, 120 oC

1

To test the feasibility of our hypothesis, the acyclic precursor 1a obtained via Ugi-4CR of 2-ethynylbenzaldehyde, 4methoxybenzylamine, tert-butyl isocyanide and phenylpropiolic acid, was chosen as a model substrate (Table 1). Employment of the in suit formed cationic gold(I) catalyst [IPrAu]+[OTf]- from IPrAuCl/AgOTf (5 mol%) in DCE at 60 o C for 16 h gave the expected pyrido[2,1-a]isoindol-4(6H)-one 2a in 43% yield along with 22% of the spiroisoquinolinepyrrole-3,5'-dione 3a (entry 1). Further gradually increasing the reaction temperature to 120 oC selectively delivered the polyheterocycle 2a in the highest yield of 81% along with traces of spiroheterocycle 3a (entries 2-4). A reduced reaction time led to a lower yield of 2a (8 h, entry 5). Employing IPrAuCl with other chloride scavengers such as AgBF4, AgSbF6 or AgNTf2 failled to ameliorate the yield of 2a (entries 6-8). No product 2a was observed in the case of Au(PPh3)Cl/AgOTf, AuCl and AuCl3 (entries 9-11). A diminished yield of 2a was detected while changing the solvent to MeCN or toluene (entries 12 and 13). Treating with IPrAuCl or AgOTf separately resulted in almost no conversion (entries14 and 15). No target product 2a was detected when employing the heterogeneous nano-gold catalyst [Au@AlSBA15] (entry 16).16

Entry

O

3

Figure 1. Representative Bioactive (Spiro)polyheterocycles

tBu HN O

CONHR4

IPrAuCl/AgOTf (5 mol%)

N R3

R2

Table 1. Optimization of the Reaction Conditions

O O

Yield of 3a/% 22b